Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs

Question 561: All of the following antimicrobials require dose reduction in mild renal failure EXCEPT?

A. Ciprofloxacin
B. Clindamycin (Correct Answer)
C. Cefotaxime
D. Ethambutol

Explanation: ### Explanation The primary principle behind dose adjustment in renal failure is the **route of elimination**. Drugs that are primarily excreted unchanged by the kidneys require dose reduction to prevent accumulation and toxicity, whereas drugs metabolized by the liver do not. **1. Why Clindamycin is the Correct Answer:** Clindamycin is primarily metabolized by the **liver** into inactive metabolites, which are then excreted in bile and urine. Because its clearance is not significantly dependent on renal function, no dose adjustment is required in patients with renal impairment (mild to severe). **2. Analysis of Incorrect Options:** * **Ciprofloxacin (Option A):** This fluoroquinolone is primarily eliminated via renal excretion (tubular secretion and glomerular filtration). Dose reduction is mandatory when Creatinine Clearance (CrCl) falls below 30-50 mL/min. * **Cefotaxime (Option B):** Most cephalosporins (except Ceftriaxone) are renally excreted. Cefotaxime and its active metabolite (desacetylcefotaxime) accumulate in renal failure, necessitating a dose reduction (usually by half) when CrCl is <20 mL/min. * **Ethambutol (Option D):** Approximately 80% of ethambutol is excreted unchanged in the urine. It is notorious for causing optic neuritis; since this toxicity is dose-dependent, strict dose adjustment (increasing the interval) is required in renal failure to prevent blindness. **3. NEET-PG High-Yield Pearls:** * **Safe in Renal Failure (No dose change):** Clindamycin, Ceftriaxone, Erythromycin/Azithromycin, Doxycycline, Chloramphenicol, and Rifampicin. * **Contraindicated in Renal Failure:** Tetracyclines (except Doxycycline), Nitrofurantoin, and Nalidixic acid. * **Most Nephrotoxic:** Aminoglycosides (Amikacin/Gentamicin) and Amphotericin B. * **Rule of Thumb:** For drugs with a narrow therapeutic index that are >60% renally excreted, always look for dose adjustment options in exam questions.

Question 562: Saline diuresis is useful in the management of toxicity for which of the following drugs, except?

A. Ethyl alcohol
B. Isoniazid (INH)
C. Lithium
D. Salicylates (Correct Answer)

Explanation: **Explanation:** The correct answer is **Salicylates (Option D)**. While diuresis is used in salicylate poisoning, **Saline Diuresis** alone is insufficient. The standard of care is **Alkaline Diuresis** (using Sodium Bicarbonate). **1. Why Salicylates is the correct answer:** Salicylates are weak acids. According to the principle of ion trapping, increasing the urinary pH (alkalinization) converts the drug into its ionized form, which cannot be reabsorbed by the renal tubules, thus enhancing excretion. Simple saline diuresis (increasing volume without changing pH) is not the preferred method because it does not optimize the ionization state of the drug. **2. Analysis of other options:** * **Ethyl alcohol (A):** Alcohol is primarily metabolized by the liver, but a small portion is excreted unchanged in the urine. Saline diuresis can marginally assist in clearing the drug and, more importantly, manages the dehydration and ketoacidosis often associated with toxicity. * **Isoniazid (B):** INH is water-soluble and excreted renally. Saline diuresis helps accelerate its clearance, although the definitive management involves Pyridoxine (Vitamin B6). * **Lithium (C):** Lithium is a monovalent cation handled by the kidneys similarly to Sodium. In lithium toxicity, the body often retains lithium in an attempt to conserve sodium. Saline diuresis (Normal Saline) is the **treatment of choice** because the sodium load inhibits the proximal tubular reabsorption of lithium, promoting its excretion. **High-Yield NEET-PG Pearls:** * **Forced Alkaline Diuresis:** Used for weak acids like **Salicylates** and **Phenobarbitone**. * **Forced Acid Diuresis:** Historically used for weak bases like **Amphetamines** and **Quinine**, but now largely avoided due to the risk of precipitating myoglobinuria and renal failure. * **Lithium Toxicity:** Always prioritize **Normal Saline** to restore sodium balance; if levels are >4 mEq/L, Hemodialysis is the gold standard.

Question 563: Type of respiration observed in morphine poisoning is:

A. Slow (Correct Answer)
B. Rapid
C. Rapid shallow
D. Diaphragmatic

Explanation: **Explanation:** The hallmark of opioid toxicity, including morphine poisoning, is **central nervous system and respiratory depression**. Morphine acts primarily on the **mu (μ) opioid receptors** located in the brainstem respiratory centers. This stimulation leads to a direct reduction in the responsiveness of the respiratory center to carbon dioxide (CO2) levels. Consequently, the respiratory rate decreases significantly, often falling to 2–4 breaths per minute. This is clinically described as **slow and shallow breathing**. **Analysis of Options:** * **A. Slow (Correct):** Morphine depresses the rhythmicity and sensitivity of the medullary respiratory center, leading to a marked decrease in respiratory rate (bradypnea). * **B. Rapid:** Rapid breathing (tachypnea) is characteristic of stimulants or conditions like salicylate poisoning, where the respiratory center is directly stimulated. * **C. Rapid shallow:** This pattern is often seen in restrictive lung diseases or pleuritic pain, but not in opioid overdose. * **D. Diaphragmatic:** While breathing may become primarily diaphragmatic if intercostal muscles are affected, the defining characteristic of morphine poisoning is the rate (slowness), not the muscle group used. **High-Yield Clinical Pearls for NEET-PG:** * **The Classic Triad of Morphine Poisoning:** 1. Respiratory depression (Slow breathing), 2. Pinpoint pupils (Miosis), and 3. Coma/Altered sensorium. * **Exception to Miosis:** In severe hypoxia or Pethidine (Meperidine) overdose, pupils may be dilated (mydriasis). * **Specific Antagonist:** **Naloxone** is the drug of choice for reversing respiratory depression. * **Cause of Death:** Respiratory failure is the most common cause of death in acute opioid overdose.

Question 564: Which of the following is NOT given to prevent rejection in organ transplantation?

A. Hyperimmune sera (Correct Answer)
B. Steroids
C. T cell inhibitors
D. Azathioprine

Explanation: The goal of immunosuppressive therapy in organ transplantation is to inhibit the recipient's immune system to prevent it from attacking the donor organ (graft rejection) [1]. **Why Hyperimmune Sera is the correct answer:** Hyperimmune sera (also known as specific immunoglobulins) are preparations containing high titers of antibodies against specific pathogens (e.g., Hepatitis B, Tetanus, Rabies). They provide **passive immunity** to prevent or treat infections. They are **not** used to prevent transplant rejection; in fact, administering pre-formed antibodies could theoretically increase the risk of a hypersensitivity reaction rather than suppressing the immune response [3]. **Why the other options are incorrect:** * **Steroids (e.g., Prednisolone):** These are the backbone of transplant regimens. They inhibit the expression of multiple cytokines (like IL-1 and IL-6) and have broad anti-inflammatory and lympholytic effects [1]. * **T-cell Inhibitors:** This group includes Calcineurin inhibitors (e.g., **Cyclosporine** [2], **Tacrolimus**) and mTOR inhibitors (e.g., **Sirolimus**) [3]. Since T-cells are the primary mediators of graft rejection, inhibiting their activation or proliferation is crucial [1, 2]. * **Azathioprine:** This is a purine antimetabolite (prodrug of 6-Mercaptopurine) that inhibits DNA synthesis, thereby preventing the clonal expansion of lymphocytes during an immune response [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Tacrolimus is generally preferred over Cyclosporine due to higher potency and a better side-effect profile (though it has a higher risk of post-transplant diabetes). * **Gingival Hyperplasia:** A classic side effect associated with Cyclosporine (also seen with Phenytoin and Nifedipine). * **Myelosuppression:** The dose-limiting toxicity of Azathioprine, especially in patients with **TPMT deficiency**. * **Antilymphocyte Globulin (ALG):** Unlike hyperimmune sera, ALG/ATG is used in transplantation to deplete T-lymphocytes during acute rejection episodes [1, 3].

Question 565: What is true about thalidomide?

A. It exerts antitumour activity in some solid malignant tumours.
B. It exerts antileprotic action.
C. It ameliorates cancer-associated cachexia. (Correct Answer)
D. All of the above.

Explanation: **Explanation:** **Thalidomide** is a multifaceted drug originally used as a sedative, famously withdrawn due to severe teratogenicity (phocomelia), and later repurposed for its potent immunomodulatory and anti-angiogenic properties. **Why Option C is correct:** Thalidomide is a potent **inhibitor of Tumor Necrosis Factor-alpha (TNF-α)**, also known as "cachectin." TNF-α is the primary cytokine responsible for the profound weight loss, muscle wasting, and anorexia seen in advanced malignancies. By suppressing TNF-α production, thalidomide helps **ameliorate cancer-associated cachexia**, improving the quality of life in palliative care settings. **Analysis of Incorrect Options:** * **Option A:** While thalidomide has anti-angiogenic properties, it has shown disappointing results in most **solid tumors**. Its primary oncological success is in **Multiple Myeloma** (where it is a first-line agent along with dexamethasone). * **Option B:** Thalidomide does **not** have direct antileprotic (antimicrobial) action against *M. leprae*. Instead, it is the drug of choice for **Erythema Nodosum Leprosum (ENL)**, a Type 2 lepra reaction. It treats the *complication* of leprosy, not the infection itself. **High-Yield NEET-PG Pearls:** 1. **Mechanism:** Inhibits TNF-α and inhibits angiogenesis by suppressing basic Fibroblast Growth Factor (bFGF) and Vascular Endothelial Growth Factor (VEGF). 2. **Clinical Uses:** Multiple Myeloma, ENL (Type 2 Lepra reaction), HIV-associated wasting/aphthous ulcers. 3. **Teratogenicity:** Causes **Phocomelia** (seal-like limbs). It is contraindicated in pregnancy (Category X). 4. **Side Effects:** Peripheral neuropathy (most common dose-limiting toxicity), sedation, and increased risk of thromboembolism (especially when combined with steroids).

Question 566: Estimation of plasma cholinesterase levels may be helpful in the management of poisoning with which of the following?

A. Dhatura
B. Barbiturate
C. Organophosphorus (Correct Answer)
D. Opium

Explanation: **Explanation:** **1. Why Organophosphorus (OP) is Correct:** Organophosphorus compounds act by irreversibly inhibiting the enzyme **Acetylcholinesterase (AChE)** and its sister enzyme, **Plasma Cholinesterase (Butyrylcholinesterase/PChE)**. This leads to an accumulation of acetylcholine at synapses, causing a cholinergic crisis. * **Clinical Utility:** Estimation of PChE levels is a sensitive biomarker for OP poisoning. While RBC cholinesterase reflects the severity of poisoning more accurately, **Plasma Cholinesterase (PChE)** is the first to decrease and is easier to measure. A reduction to <50% of normal levels is diagnostic, and <25% indicates severe poisoning. It is also used to monitor the effectiveness of treatment and recovery. **2. Why Other Options are Incorrect:** * **A. Dhatura:** This is an anticholinergic (atropine-like) poison. It blocks muscarinic receptors but does not affect cholinesterase enzyme levels. * **B. Barbiturate:** These are CNS depressants that act by enhancing GABAergic transmission. Diagnosis is based on clinical presentation (coma, respiratory depression) and toxicology screens, not cholinesterase. * **D. Opium:** Opioids act on mu, kappa, and delta receptors. Diagnosis is clinical (triad of miosis, respiratory depression, and coma) and confirmed by response to Naloxone. **3. NEET-PG High-Yield Pearls:** * **RBC Cholinesterase vs. Plasma Cholinesterase:** RBC cholinesterase is more specific and correlates better with neurological symptoms, but PChE is more sensitive for initial screening. * **Management:** The definitive treatment for OP poisoning involves **Atropine** (to reverse muscarinic effects) and **Pralidoxime (2-PAM)** (to reactivate the enzyme before "aging" occurs). * **Other uses of PChE:** Low levels of plasma cholinesterase are also seen in patients with **Succinylcholine apnea** due to genetic deficiency of the enzyme.

Question 567: Which of the following drugs can cause eosinophilic pneumonia?

A. Nitrofurantoin
B. Amiodarone (Correct Answer)
C. Sulfonamides
D. Non-steroidal anti-inflammatory drugs (NSAIDs)

Explanation: **Explanation:** **Amiodarone** is a Class III antiarrhythmic drug known for its extensive side-effect profile, particularly involving the lungs. While it most commonly causes chronic interstitial pneumonitis and pulmonary fibrosis, it is a well-documented cause of **acute eosinophilic pneumonia**. The mechanism involves both direct toxic effects on pneumocytes and an indirect immunological hypersensitivity reaction, leading to the accumulation of eosinophils in the alveolar spaces. **Analysis of Options:** * **A. Nitrofurantoin:** While Nitrofurantoin is a classic cause of drug-induced lung disease (DILD), it typically presents as an acute hypersensitivity pneumonitis or chronic interstitial fibrosis. While it can cause peripheral eosinophilia, Amiodarone is more frequently associated with the specific pathological diagnosis of eosinophilic pneumonia in clinical vignettes. * **C. Sulfonamides:** These are more commonly associated with systemic hypersensitivity reactions like Stevens-Johnson Syndrome or simple pulmonary infiltrates with eosinophilia (Löffler syndrome), rather than frank eosinophilic pneumonia. * **D. NSAIDs:** These drugs are primarily linked to aspirin-exacerbated respiratory disease (AERD) and bronchospasm. While they can rarely cause pulmonary infiltrates, they are not the primary association for this condition. **NEET-PG High-Yield Pearls:** * **Amiodarone Toxicity:** Remember the "6 P's": **P**ulmonary fibrosis/pneumonia, **P**hotodermatitis (Blue-grey skin), **P**eripheral neuropathy, **P**rolonged QT, **P**apillary thyroid changes (Hypo/Hyper), and **P**earl-like corneal deposits. * **Diagnosis:** Drug-induced eosinophilic pneumonia is characterized by "photographic negative" pulmonary edema on CXR (peripheral opacities) and >25% eosinophils on Bronchoalveolar Lavage (BAL). * **Other common triggers:** Daptomycin, Minocycline, and Penicillamine.

Question 568: Urine alkalinization is beneficial in ameliorating the toxicity of which of the following drugs?

A. Cytarabine
B. Ifosfamide
C. Cisplatin
D. Methotrexate (Correct Answer)

Explanation: **Explanation:** The correct answer is **Methotrexate**. **Mechanism of Action & Rationale:** Methotrexate (MTX) and its metabolites (specifically 7-hydroxymethotrexate) are poorly soluble in acidic environments. At a low urinary pH, MTX can precipitate in the renal tubules, leading to **crystalluria** and acute obstructive nephropathy. **Urine alkalinization** (using intravenous sodium bicarbonate to achieve a pH > 7.0) significantly increases the ionization and solubility of MTX, thereby facilitating its excretion and preventing renal toxicity. Vigorous hydration is also essential. **Analysis of Incorrect Options:** * **A. Cytarabine:** Its dose-limiting toxicity is primarily hematological (bone marrow suppression) and cerebellar ataxia at high doses. It does not cause renal crystal formation. * **B. Ifosfamide:** While it causes hemorrhagic cystitis (due to the metabolite acrolein), the standard preventive measure is **MESNA** and hydration, not urine alkalinization. * **C. Cisplatin:** Its primary toxicity is acute tubular necrosis. Prevention involves aggressive hydration with **normal saline** and sometimes osmotic diuresis (Mannitol), but alkalinization does not specifically mitigate its nephrotoxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Urine Alkalinization** is also used for toxicities of **Salicylates (Aspirin)** and **Phenobarbital** (weakly acidic drugs). * **Urine Acidification** (using Ammonium Chloride) was historically used for weak bases like Amphetamines, but is now rarely practiced due to the risk of systemic acidosis. * **Leucovorin (Folinic acid) Rescue** is used specifically for MTX toxicity to bypass the inhibited dihydrofolate reductase. * **Glucarpidase** is an enzyme used as an antidote for toxic MTX levels in patients with renal failure.

Question 569: Pneumopathy is a side effect of all EXCEPT:

A. Alpha methyldopa (Correct Answer)
B. Busulphan
C. Melphalan
D. Nitrofurantoin

Explanation: **Explanation:** **Pneumopathy** (specifically drug-induced interstitial lung disease or pulmonary fibrosis) is a well-documented adverse effect of several chemotherapeutic agents and certain antibiotics. **1. Why Alpha-methyldopa is the correct answer:** Alpha-methyldopa is a centrally acting anti-hypertensive (alpha-2 agonist). Its primary significant side effects are **Coombs-positive hemolytic anemia**, drug-induced lupus, and hepatotoxicity. It is **not** associated with pulmonary fibrosis or pneumopathy. **2. Analysis of Incorrect Options (Drugs that cause Pneumopathy):** * **Busulphan:** This alkylating agent is notorious for causing "Busulphan Lung," characterized by progressive pulmonary fibrosis. * **Melphalan:** Another alkylating agent used in multiple myeloma, it is known to cause interstitial pneumonitis and fibrosis, though less frequently than busulphan. * **Nitrofurantoin:** Used for UTIs, it can cause both acute hypersensitivity pneumonitis and chronic pulmonary fibrosis (especially with long-term prophylactic use). **Clinical Pearls for NEET-PG:** * **Mnemonic for Pulmonary Fibrosis drugs:** "**B**-**A**-**M**-**N**-**P**" (**B**leomycin/Busulphan, **A**miodarone, **M**ethotrexate/Melphalan, **N**itrofurantoin, **P**henytoin). * **Bleomycin** is the most common chemotherapy-induced cause; it is dose-dependent (limit total dose to <400 units). * **Amiodarone** contains iodine and accumulates in macrophages, leading to "foamy macrophages" on histology and pulmonary toxicity. * **Methotrexate** causes a hypersensitivity-like pneumonitis that may be reversible upon cessation.

Question 570: Which immunosuppressant drug inhibits the action of IL-3 without inhibiting its transcription?

A. Prednisolone
B. Cyclosporine
C. Tacrolimus
D. Sirolimus (Correct Answer)

Explanation: ### Explanation The correct answer is **Sirolimus (Rapamycin)**. #### 1. Why Sirolimus is Correct The mechanism of action of Sirolimus involves binding to the intracellular protein **FKBP-12**. This complex inhibits the **mTOR (mammalian Target of Rapamycin)** pathway. Unlike calcineurin inhibitors, Sirolimus does not prevent the production (transcription) of cytokines like IL-2 or IL-3. Instead, it inhibits the **downstream signaling** and cellular response to these cytokines. Therefore, while IL-3 is produced normally, its action on T-cell proliferation is blocked. #### 2. Why Other Options are Incorrect * **Prednisolone:** Glucocorticoids act by inhibiting the expression of multiple inflammatory genes. They inhibit the **transcription** of various cytokines (IL-1, IL-2, IL-3, IL-6, TNF-α) by interfering with NF-κB signaling. * **Cyclosporine:** This is a **Calcineurin inhibitor**. It binds to Cyclophilin to inhibit calcineurin, preventing the dephosphorylation of NFAT (Nuclear Factor of Activated T-cells). This directly blocks the **transcription** of IL-2 and IL-3. * **Tacrolimus:** Similar to Cyclosporine, it is a **Calcineurin inhibitor** (though it binds to FKBP-12). It also prevents the **transcription** of IL-2 and IL-3. #### 3. High-Yield Clinical Pearls for NEET-PG * **Sirolimus Side Effect:** Notably causes **hyperlipidemia** (increased cholesterol and triglycerides) and **thrombocytopenia**. * **Kidney Sparing:** Unlike Cyclosporine and Tacrolimus, Sirolimus is **not nephrotoxic**, making it useful in patients with renal impairment. * **Drug-Eluting Stents:** Sirolimus is frequently used in coronary stents to prevent restenosis by inhibiting smooth muscle cell proliferation. * **Mnemonic:** **C**alcineurin inhibitors block **C**reation (transcription) of cytokines; **S**irolimus blocks **S**ignaling (action) of cytokines.

Practice by Chapter

Principles of Clinical Pharmacology

Practice Questions

Therapeutic Drug Monitoring

Practice Questions

Drug Toxicity and Overdose

Practice Questions

Antidotes and Their Applications

Practice Questions

Management of Drug Poisoning

Practice Questions

Drug-Induced Liver Injury

Practice Questions

Drug-Induced Kidney Injury

Practice Questions

Drug-Induced Blood Dyscrasias

Practice Questions

Drug-Induced QT Prolongation

Practice Questions

Pharmacovigilance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free